Properties of the activation by pepsin of inactive renin in human amniotic fluid.
1. The renin present in human amniotic fluid was found to have an apparent Mr of 58 000 by gel filtration and is thus bigger than renin in untreated kidney extracts and plasma (Mr approximately 40 000). 2. Treatment with pepsin (40 microgram/ml pH 4.8, 2 h, 22 degrees C) caused a 6-fold increase in activity of this renin species, although Mr was not very different (57 000). 3. Unlike renal renin, renin in human amniotic fluid was not a glycoprotein and behaved similarly on concanavalin A-Sepharose before and after activation by pepsin. 4. Ion-exchange chromatography demonstrated a small change in the ionization properties of human amniotic fluid renin after activation by pepsin. 5. Pepsin-mediated activation resulted in a five-fold increase in V, but only a small decrease in the Km of renin to 39% of normal, so that the increase in activity observed was not due to an increase in the affinity of the enzyme for its substrate. The kinetic data were consistent with the theory of noncompetitive inhibition. 6. The activation of human amniotic fluid renin by pepsin may be caused by a change in the tertiary structure of the molecule subsequent to a proteolytic action that does not remove detectable polypeptide components.
D000653:Amniotic Fluid / Q000201:enzymology*; D002846:Chromatography, Affinity; D003208:Concanavalin A; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D007668:Kidney / Q000201:enzymology; D007700:Kinetics; D008970:Molecular Weight; D010434:Pepsin A / Q000378:metabolism*; D011247:Pregnancy; D012083:Renin / Q000302:isolation & purification / Q000378:metabolism*; D012685:Sepharose
D003208:Concanavalin A; D012685:Sepharose; D010434:Pepsin A; D012083:Renin